Spatially encoded biological assays

Patent metadata

Field	Value
Publication number	US-12391980-B2
Application number	US-202519074001-A
Country	US
Kind code	B2
Filing date	Mar 7, 2025
Priority date	Apr 5, 2010
Publication date	Aug 19, 2025
Grant date	Aug 19, 2025

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

First claim

The invention claimed is:

1. A method comprising:
(a) providing a substrate comprising a plurality of nucleic acid molecules each having (i) a first sequence configured to bind a target biological molecule in a tissue section, and (ii) a second sequence corresponding to a location on the substrate;
(b) contacting the tissue section with the substrate;
(c) capturing the target biological molecule from the tissue section onto a nucleic acid molecule of the plurality of nucleic acid molecules using the first sequence; and
(d) generating a nucleic acid molecule comprising (i) a sequence of the captured target biological molecule, or a complement thereof, and (ii) the second sequence corresponding to the location on the substrate, or a complement thereof.

2. The method of claim 1 , wherein the tissue section is a fresh-frozen or formalin-fixed paraffin-embedded tissue sample.

3. The method of claim 1 , wherein the target biological molecule is an RNA molecule.

4. The method of claim 3 , wherein the RNA molecule is an mRNA molecule.

5. The method of claim 1 , wherein the target biological molecule is a DNA molecule.

6. The method of claim 1 , wherein (c) comprises hybridizing the target biological molecule to the first sequence of the nucleic acid molecule.

7. The method of claim 1 , wherein (c) comprises coupling the target biological molecule to the nucleic acid molecule.

8. The method of claim 7 , wherein the coupling comprises ligation.

9. The method of claim 8 , wherein the ligation comprises enzymatic ligation.

10. The method of claim 1 , wherein (d) comprises extending the nucleic acid molecule using the target biological molecule as a template.

11. The method of claim 10 , wherein the extending is performed by a polymerase.

12. The method of claim 1 , wherein the substrate is a flow cell.

13. The method of claim 1 , wherein the plurality of nucleic acid molecules further comprises a universal priming site.

14. The method of claim 1 , further comprising staining the tissue section.

15. The method of claim 14 , wherein the staining is selected from immunohistochemistry or hematoxylin and eosin staining.

16. The method of claim 14 , further comprising obtaining an image of the stained tissue section.

17. The method of claim 1 , further comprising amplifying the generated nucleic acid molecule.

18. The method of claim 17 , further comprising sequencing all or a portion of the amplified, generated nucleic acid molecule.

19. The method of claim 1 , further comprising determining the location on the substrate where the target biological molecule was captured.

20. The method of claim 19 , wherein the method further comprises mapping the location of the target biological molecule to a location in the tissue section.

Assignees

• Prognosys Biosciences Inc

Inventors

• Chee Mark S

Classifications

• G01N2458/40

  Rare earth chelates · CPC title

• G01N33/6848

  Methods of protein analysis involving mass spectrometry · CPC title

• C12Q2600/158

  Expression markers · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• C12Q1/6858

  Allele-specific amplification · CPC title